Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue
暂无分享,去创建一个
J. Erjefält | L. Bjermer | A. Humbles | M. Mori | R. Kolbeck | A. Walls | P. Newbold | C. Sanden | P. Jogdand | Jimmie Jönsson | J. Kearley | Premkumar Siddhuraj | J. Jönsson | P. Siddhuraj | Michiko Mori
[1] S. Sridhar,et al. Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases , 2019, Respiratory Research.
[2] H. Karasuyama,et al. Basophils trigger emphysema development in a murine model of COPD through IL-4–mediated generation of MMP-12–producing macrophages , 2018, Proceedings of the National Academy of Sciences.
[3] S. Rennard,et al. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. , 2018, The Lancet. Respiratory medicine.
[4] M. Cosio,et al. Blood Eosinophilia Neither Reflects Tissue Eosinophils nor Worsens Clinical Outcomes in Chronic Obstructive Pulmonary Disease. , 2017, American journal of respiratory and critical care medicine.
[5] Dave Singh,et al. Pulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil counts. , 2017, The Journal of allergy and clinical immunology.
[6] I. Pavord,et al. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease , 2017, The New England journal of medicine.
[7] D. Lynch,et al. American Thoracic Society/National Heart, Lung, and Blood Institute Asthma‐Chronic Obstructive Pulmonary Disease Overlap Workshop Report , 2017, American journal of respiratory and critical care medicine.
[8] Y. Okamoto,et al. Th2 Cells in Health and Disease. , 2017, Annual review of immunology.
[9] P. Thomas,et al. Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus , 2017, The Journal of Immunology.
[10] S. Russell,et al. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart , 2016, European journal of immunology.
[11] B. Nordestgaard,et al. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. , 2016, American journal of respiratory and critical care medicine.
[12] W. Fokkens,et al. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs , 2016, Nature Immunology.
[13] R. Bowler,et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs , 2016, Nature Immunology.
[14] G. Joos,et al. Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung , 2016, PloS one.
[15] C. Brightling,et al. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease , 2016, Therapeutic advances in chronic disease.
[16] J. Erjefält,et al. IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis. , 2015, American journal of respiratory and critical care medicine.
[17] Thomas A. Wynn,et al. Type 2 cytokines: mechanisms and therapeutic strategies , 2015, Nature Reviews Immunology.
[18] G. Criner,et al. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. , 2015, Immunity.
[19] C. Brightling,et al. Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease , 2015, Respirology.
[20] H. Karasuyama,et al. Basophils have emerged as a key player in immunity. , 2014, Current opinion in immunology.
[21] Penny A. Rudd,et al. Dual Proinflammatory and Antiviral Properties of Pulmonary Eosinophils in Respiratory Syncytial Virus Vaccine-Enhanced Disease , 2014, Journal of Virology.
[22] E. Bleecker,et al. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. , 2014, The Lancet. Respiratory medicine.
[23] Dave Singh,et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics , 2014, European Respiratory Journal.
[24] Ivo F. Sbalzarini,et al. MosaicIA: an ImageJ/Fiji plugin for spatial pattern and interaction analysis , 2013, BMC Bioinformatics.
[25] James J. Lee,et al. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia , 2013, Allergy.
[26] J. D. Di Santo,et al. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells , 2013, Proceedings of the National Academy of Sciences.
[27] A. Bergqvist,et al. Appearance of remodelled and dendritic cell-rich alveolar-lymphoid interfaces provides a structural basis for increased alveolar antigen uptake in chronic obstructive pulmonary disease , 2013, Thorax.
[28] A. McKenzie,et al. Innate lymphoid cells — how did we miss them? , 2013, Nature Reviews Immunology.
[29] Christopher E Brightling,et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.
[30] Hergen Spits,et al. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. , 2012, Annual review of immunology.
[31] Christopher E Brightling,et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. , 2011, American journal of respiratory and critical care medicine.
[32] G. Joos,et al. Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease , 2011 .
[33] R. Melo,et al. Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses. , 2010, Histology and histopathology.
[34] Sanjay Sethi,et al. New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. , 2009, Proceedings of the American Thoracic Society.
[35] Wim Timens,et al. The pathology of chronic obstructive pulmonary disease. , 2009, Annual review of pathology.
[36] P. Barnes. Immunology of asthma and chronic obstructive pulmonary disease , 2008, Nature Reviews Immunology.
[37] H. Boezen,et al. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies , 2008, European Respiratory Journal.
[38] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[39] N. Pride,et al. Exhaled nitric oxide from lung periphery is increased in COPD , 2005, European Respiratory Journal.
[40] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[41] J. Oliver,et al. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. , 2001, American journal of respiratory and critical care medicine.
[42] J. Wedemeyer,et al. Roles of mast cells and basophils in innate and acquired immunity. , 2000, Current opinion in immunology.
[43] J. Erjefält,et al. New aspects of degranulation and fates of airway mucosal eosinophils. , 2000, American journal of respiratory and critical care medicine.
[44] S. Johnston,et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.
[45] J. D. de Monchy,et al. Desensitization of the adenylyl cyclase system in peripheral blood mononuclear cells from patients with asthma three hours after allergen challenge. , 1993, Journal of Allergy and Clinical Immunology.
[46] J. Bousquet,et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. , 1993, The Journal of allergy and clinical immunology.
[47] P. Venge,et al. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. , 1990, The American review of respiratory disease.
[48] D. Voehringer,et al. Regulation of eosinophil development and survival , 2017, Current opinion in hematology.
[49] A. Bergqvist,et al. Alveolar T-helper type-2 immunity in atopic asthma is associated with poor clinical control. , 2015, Clinical science.
[50] J. Flanagan,et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.
[51] Prabir Ray,et al. A critical role for NF-κB in Gata3 expression and TH2 differentiation in allergic airway inflammation , 2001, Nature Immunology.